TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.

Joaquim Bellmunt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.